ULURU receives marketing approval for Altrazeal in New Zealand
The company expects to launch Altrazeal in six additional markets for human and veterinary use, in the near future. The company also expects to receive approval in the
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.